Company intelligence / Profile preview

Galen Robotics

Baltimore, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Galen Robotics received FDA de novo clearance for its Galen ES robotic surgical assistant for ENT procedures[2]. The platform is designed to stabilize surgeon hand movements, reduce tremors, and improve precision in minimally invasive soft tissue surgery. However, the company was forced into Chapter 7 bankruptcy by creditors, owing $2.2 million and facing multiple lawsuits[8].

Therapeutic areas: CardiovascularNeurologyOther
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Johns Hopkins UniversityHarvard UniversityStanford UniversityUniversity of California San Francisco (UCSF)Keck School of Medicine at University of Southern CaliforniaBrigham and Women's Hospital

Beyond the preview

Go deeper on Galen Robotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galen Robotics.

Explore the full profile